JP4826711B2 - Needle - Google Patents

Needle Download PDF

Info

Publication number
JP4826711B2
JP4826711B2 JP2005102395A JP2005102395A JP4826711B2 JP 4826711 B2 JP4826711 B2 JP 4826711B2 JP 2005102395 A JP2005102395 A JP 2005102395A JP 2005102395 A JP2005102395 A JP 2005102395A JP 4826711 B2 JP4826711 B2 JP 4826711B2
Authority
JP
Japan
Prior art keywords
injection needle
inclined surface
angle
needle
length
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2005102395A
Other languages
Japanese (ja)
Other versions
JP2006280503A (en
Inventor
宏太 高橋
佳邦 内田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nipro Corp
Original Assignee
Nipro Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nipro Corp filed Critical Nipro Corp
Priority to JP2005102395A priority Critical patent/JP4826711B2/en
Priority to PCT/JP2006/306753 priority patent/WO2006106880A1/en
Priority to KR1020077022383A priority patent/KR101291970B1/en
Priority to CN2006800099449A priority patent/CN101151059B/en
Publication of JP2006280503A publication Critical patent/JP2006280503A/en
Application granted granted Critical
Publication of JP4826711B2 publication Critical patent/JP4826711B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/32Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/32Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3286Needle tip design, e.g. for improved penetration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/19Constructional features of carpules, syringes or blisters
    • A61M2205/192Avoiding coring, e.g. preventing formation of particles during puncture
    • A61M2205/195Avoiding coring, e.g. preventing formation of particles during puncture by the needle tip shape

Description

本発明は医療用の注射針に関し、特に、内痔核組織内への薬剤注射に好適な注射針に関する。   The present invention relates to a medical injection needle, and more particularly to an injection needle suitable for drug injection into an internal hemorrhoid tissue.

肛門部の血行障害(鬱血)により生じる痔の一種として、痔核がある。この痔核は、肛門部の歯状線よりも上部に発生する内痔核と、下部に発生する外痔核に分けられ、内痔核が全体の40〜60%を占めている。   Hemorrhoids are a type of hemorrhoid caused by blood circulation disorders (congestion) in the anus. This hemorrhoid is divided into an inner hemorrhoid that occurs above the tooth line of the anus and an outer hemorrhoid that occurs at the lower part, and the inner hemorrhoid accounts for 40-60% of the total.

現在の内痔核の治療では、軽症から中等症の場合には、薬剤治療等による保存療法が行われ、又、重症化した場合には、手術による根治療法が行われている。しかし、手術による場合には、術後の疼痛や出血の不安があると共に、10日前後の入院が必要になることから、病院に行かずに、悩む患者が多いのが実情である。   In the present treatment of internal hemorrhoids, conservative therapy such as drug treatment is performed in cases of mild to moderate disease, and radical treatment by surgery is performed in the case of becoming severe. However, in the case of surgery, since there is anxiety about postoperative pain and bleeding, and hospitalization is required for about 10 days, there are many patients who suffer without going to the hospital.

この問題を解決するために、重症の内痔核の場合でも、手術ではなく、次のような薬剤治療が提案されている。この治療では、柔らかい内痔核組織内に薬剤(薬液)を直接注射して、内痔核組織を硬化退縮させる治療が行われる。ところで、上記治療では、薬剤が内痔核組織内ではなく、内痔核組織下の硬い直腸筋層に誤注射された場合には、重篤な副作用が懸念される。   In order to solve this problem, the following drug treatment is proposed instead of surgery even in the case of severe internal hemorrhoids. In this treatment, a drug (medical solution) is directly injected into a soft internal hemorrhoid tissue to cure the internal hemorrhoid tissue. By the way, in the above treatment, there is a concern that serious side effects may occur when the drug is erroneously injected not into the internal hemorrhoid tissue but into the hard rectal muscle layer under the internal hemorrhoid tissue.

そのため、上記治療に際しては、注射針を内痔核組織(痔患部層)に穿刺(刺通)した際には、その刺通抵抗が低く、注射針を内痔核組織下の直腸筋層に誤穿刺した際には、その刺通抵抗が大となる注射針、即ち、刺通抵抗が相違して、内痔核組織と直腸筋層を判別可能な注射針が必要となる。しかしながら、従来においては、上記のような注射針が存在しなかったのが実情である。   Therefore, during the above treatment, when the needle is punctured (pierced) into the internal hemorrhoid tissue (affected area layer), the puncture resistance is low, and the needle is erroneously punctured into the rectal muscle layer under the internal hemorrhoid tissue. In such a case, an injection needle whose piercing resistance is large, that is, an injection needle capable of discriminating the internal hemorrhoidal tissue from the rectal muscle layer is required. However, in the past, the actual situation is that there was no injection needle as described above.

解決しようとする問題点は、内痔核組織内への薬剤の注射時に、刺通抵抗の相違により、内痔核組織と、その組織下の直腸筋層を判別可能な注射針が存在しなかった点である。   The problem to be solved was that when a drug was injected into the internal hemorrhoid tissue, there was no injection needle that could distinguish the internal hemorrhoid tissue and the rectal muscle layer under the tissue due to the difference in piercing resistance. It is.

本発明は、上記問題を解決できる注射針を提供することを目的とし、その目的を達成するために、本発明の特徴とするところは、内痔核組織内への薬剤の注射に使用されるものであって、針管の先端部がその軸心に対して斜めに研磨されて、その研磨面が刃面とされ、刃面が、基部側にある第1傾斜面と、先端部側の両側にある一対の第2傾斜面を有し、第2傾斜面と軸心のなす角度である第2傾斜角が、第1傾斜面と軸心のなす角度である第1傾斜角よりも大とされた注射針において、両第2傾斜面のなす角度である形成角が50°〜90°とされた点にある。
尚、第1傾斜角が8〜20°とされることもある。
又、第2傾斜角が21°〜31°とされることもある。
更に、刃面の軸心方向の長さである刃面長L1が1.0〜5.0mmとされることもある。
又、第2傾斜面の軸心方向の長さを脇取り長L2とした場合に、脇取り比L2/L1が0.25〜0.65とされることもある。
An object of the present invention is to provide an injection needle that can solve the above problems, and in order to achieve the object, the present invention is characterized in that it is used for injection of a drug into the internal hemorrhoid tissue. The tip of the needle tube is polished obliquely with respect to its axis, the polished surface is used as the blade surface, and the blade surface is provided on the first inclined surface on the base side and on both sides on the tip side. The second inclination angle that is an angle formed between the second inclined surface and the axial center is larger than the first inclination angle that is an angle formed between the first inclined surface and the axial center. In the injection needle, the formation angle which is an angle formed by both the second inclined surfaces is 50 ° to 90 °.
The first inclination angle may be 8 to 20 °.
Further, the second inclination angle may be set to 21 ° to 31 °.
Furthermore, the blade surface length L1, which is the length of the blade surface in the axial direction, may be 1.0 to 5.0 mm.
Further, when the length of the second inclined surface in the axial direction is set to the side cut length L2, the side cut ratio L2 / L1 may be set to 0.25 to 0.65.

本発明によれば、注射針を内痔核組織に穿刺(刺通)した際に、その刺通抵抗が低く、注射針を内痔核組織下の直腸筋層に誤穿刺した際には、その刺通抵抗が大となるので、薬剤(薬液)を内痔核組織内に確実に注入でき、内痔核組織下の直腸筋層等の不適切な部位に薬剤を誤って注入することを防止できる。   According to the present invention, when the injection needle is punctured (pierced) into the internal hemorrhoid tissue, the piercing resistance is low, and when the injection needle is erroneously inserted into the rectal muscle layer under the internal hemorrhoid tissue, the puncture is performed. Since the through resistance is increased, the drug (medicine solution) can be reliably injected into the internal hemorrhoid tissue, and the drug can be prevented from being erroneously injected into an inappropriate site such as the rectal muscle layer under the internal hemorrhoid tissue.

本発明は、内痔核組織内への薬剤(薬液)の注射時に、刺通抵抗の相違により、内痔核組織と、その組織下の直腸筋層を判別可能な注射針を提供する。   The present invention provides an injection needle capable of discriminating an internal hemorrhoid tissue and a rectal muscle layer under the tissue by a difference in piercing resistance when a drug (medical solution) is injected into the internal hemorrhoid tissue.

以下、本発明の一実施態様を図面に基づき説明するが、以下の説明では、便宜上、図1の左を前、図1の上下を左右、図2の上を上として説明する。本発明の注射針は下記のように形成されている。即ち、直管状の針管1の先端部がその軸心Cに対して斜めに研磨(研削)されて、前方に向かって先鋭状の先鋭部2が形成され、針管1の先鋭部2を除く部分が本体3とされている。先鋭部2の上面、即ち、上記斜めに研磨された面が刃面4とされ、先端が刃先5とされている。刃面4は、基部側の第1傾斜面(第1ベベル)6と、先端部側の左右両側にある一対の第2傾斜面(第2ベベル)7を有する。第2傾斜面7は第1傾斜面6に対し連設(連続)状に形成され、又、両第2傾斜面7は左右方向に並設(連続)状に形成されている。   Hereinafter, an embodiment of the present invention will be described with reference to the drawings. In the following description, for the sake of convenience, the left of FIG. 1 will be described as the front, the top and bottom of FIG. 1 will be the left and right, and the top of FIG. The injection needle of the present invention is formed as follows. That is, the tip portion of the straight tubular needle tube 1 is polished (ground) obliquely with respect to the axis C thereof, and a sharpened sharpened portion 2 is formed toward the front, and the portion excluding the sharpened portion 2 of the needle tube 1 Is the main body 3. The upper surface of the sharpened portion 2, that is, the obliquely polished surface is the blade surface 4, and the tip is the blade edge 5. The blade surface 4 has a first inclined surface (first bevel) 6 on the base side and a pair of second inclined surfaces (second bevel) 7 on both the left and right sides on the distal end side. The second inclined surface 7 is formed in a continuous (continuous) shape with respect to the first inclined surface 6, and both the second inclined surfaces 7 are formed in a parallel (continuous) shape in the left-right direction.

針管1としては、従来と同様のものが使用されるが、表1に示すように、例えば、その長さLは、13〜70mm、高い頻度で使用される値(高頻度値)としては、44mm、その外径O.D.は0.3〜1.25mm、高い頻度で使用される値(高頻度値)としては、0.51mm、その内径I.D.は0.16〜1.04mm、高い頻度で使用される値(高頻度値)としては、0.29mmとされる。針管1の材料としては、ステンレス鋼を含む鉄鋼材料、アルミニウム、銅、チタンのような非鉄金属材料、ニッケル、コバルト、モリブテンのような耐熱材料、鉛、すずのような低融点金属、金、銀、白金のような貴金属材料およびこれらの合金が使用される。尚、針管1として、直管だけではなく、先端あるいは基端に向けてテーパー形状である筒体や、刃面4の軸心方向中途部からテーパー形状となる筒体が使用されることもある。   As the needle tube 1, the same one as the conventional one is used. As shown in Table 1, for example, the length L is 13 to 70 mm, and the value used frequently (high frequency value) is: 44 mm, outer diameter O.D. D. Is 0.3 to 1.25 mm, a frequently used value (high frequency value) is 0.51 mm, its inner diameter I.V. D. Is 0.16 to 1.04 mm, and a frequently used value (high frequency value) is 0.29 mm. The material of the needle tube 1 includes steel materials including stainless steel, non-ferrous metal materials such as aluminum, copper and titanium, heat resistant materials such as nickel, cobalt and molybdenum, low melting point metals such as lead and tin, gold, silver, Precious metal materials such as platinum and their alloys are used. As the needle tube 1, not only a straight tube but also a cylindrical body having a tapered shape toward the distal end or the proximal end, or a cylindrical body having a tapered shape from a midway portion in the axial center direction of the blade surface 4 may be used. .

Figure 0004826711
Figure 0004826711

注射針は下記のようにして従来同様に製造される。即ち、針管1に曲がりや穴詰まり或いは全体の異常が無いように、針管1を所定の長さに切断し、針基側の切断面のバリを除去する。次に、刃面4の第1・第2傾斜面6,7を下記のように研磨により形成する。この研磨加工時には、針管1が研磨時の熱により損傷せず、バリが出にくいように、適切な研磨速度で研磨を行うと共に、刃面4の第1・第2傾斜面6,7をバランスのとれた形状に形成する。   The injection needle is manufactured in the conventional manner as follows. That is, the needle tube 1 is cut to a predetermined length so that the needle tube 1 is not bent, clogged, or has an overall abnormality, and the burr on the cut surface on the needle base side is removed. Next, the first and second inclined surfaces 6 and 7 of the blade surface 4 are formed by polishing as follows. At the time of this polishing process, the needle tube 1 is polished at an appropriate polishing rate and the first and second inclined surfaces 6 and 7 of the blade surface 4 are balanced so that the needle tube 1 is not damaged by the heat at the time of polishing and it is difficult to generate burrs. Formed in a well-shaped shape.

まず、第1段階の研磨として、円盤(円柱)状の回転砥石を針管1の先端部の上方側に配置して、図6(尚、図6では、説明の便宜上、回転砥石の軸心Dと針管1の距離を実際よりも小としてある。)に示すように、平面視において、回転砥石の回転軸心Dを針管1の軸心Cに対して直交状とした後、回転砥石の外周面で針管1の先端部を研磨して、まず、刃面4を概略形成する。次に、第2段階の研磨として、刃面4の先端部を回転砥石で更に研磨するのであるが、この際には、回転砥石を針管1の軸心Cを中心として上記研磨位置から左右にそれぞれ相対的に回動させて(尚、実際には、回転砥石を回動させずに、針管1を周方向の各方向に回動させる。以下、同様である。)、回転砥石の外周面により、刃面4の先端部の左右各側を研磨する。これにより、刃面4の内、第2段階で研磨されなかった部分が第1傾斜面6となり、第2段階で研磨された部分が第2傾斜面7となる。   First, as a first stage of polishing, a disk (column) -shaped rotating grindstone is disposed above the tip of the needle tube 1, and FIG. 6 (in FIG. 6, the axis D of the rotating grindstone is used for convenience of explanation. And the distance between the needle tube 1 and the needle tube 1 is smaller than the actual distance.) In plan view, the rotational axis D of the rotating grindstone is perpendicular to the axis C of the needle tube 1 and then the outer periphery of the rotating grindstone. The tip of the needle tube 1 is polished with a surface to first roughly form the blade surface 4. Next, as the second stage of polishing, the tip of the blade surface 4 is further polished with a rotating grindstone. At this time, the rotating grindstone is moved left and right from the polishing position around the axis C of the needle tube 1. The outer peripheral surface of the rotating grindstone is rotated relative to each other (actually, the needle tube 1 is rotated in each circumferential direction without rotating the rotating grindstone. The same applies hereinafter). Thus, the left and right sides of the tip of the blade surface 4 are polished. Thus, the portion of the blade surface 4 that has not been polished in the second stage becomes the first inclined surface 6, and the portion polished in the second stage becomes the second inclined surface 7.

研磨時に発生するバリの除去時には、刃先5が損傷しないように、刃先5を覆被した後、第1傾斜面6の全体と第2傾斜面7の基部側に、外径が数十μのガラスビーズを吹き付けて(ブラスト加工)、バリを除去する。刃先5のバリは電解研磨により除去して、稜線が明確に出るようにする。その後、針管1に対して酸による防錆加工をした後、洗浄処理を行う。   When removing burrs generated during polishing, after covering the blade edge 5 so that the blade edge 5 is not damaged, the outer diameter is several tens of μm on the entire first inclined surface 6 and the base side of the second inclined surface 7. Spray glass beads (blasting) to remove burrs. The burrs on the blade edge 5 are removed by electropolishing so that the ridge line appears clearly. Thereafter, the needle tube 1 is subjected to a rust prevention treatment with an acid, and then subjected to a cleaning treatment.

ところで、注射針では、刃面4の軸心方向の長さL1が刃面長とされ、刃面長L1は、1.0〜5.0mmとされ、好ましくは、1.7±0.4mmとされる。   By the way, in the injection needle, the length L1 of the blade surface 4 in the axial direction is the blade surface length, and the blade surface length L1 is 1.0 to 5.0 mm, preferably 1.7 ± 0.4 mm. It is said.

又、第1傾斜面6は、針管の左右方向(水平方向)の径方向に平行とされると共に、全体に平坦又は略平坦とされている。第1傾斜面6と軸心Cのなす角度は第1傾斜角(第1ベベル角)αとされ、第1傾斜角αは、8〜20°とされ、好ましくは、13±2°とされる。   The first inclined surface 6 is parallel to the radial direction of the left and right direction (horizontal direction) of the needle tube, and is flat or substantially flat as a whole. The angle formed between the first inclined surface 6 and the axis C is a first inclination angle (first bevel angle) α, and the first inclination angle α is 8 to 20 °, preferably 13 ± 2 °. The

図5にも示すように、左右各側の第2傾斜面7は、軸心方向から見た際に、線対称とされて、同一形状とされており、第1傾斜面6と各第2傾斜面7の境目には、稜線9が形成されている。この稜線9は、径方向外方に向かうに従って、上位となるように、径方向に関して傾斜している。第2傾斜面7の軸心方向の長さは脇取り長L2とされて、脇取り比L2/L1が、0.25〜0.65とされ、好ましくは、0.45±0.2とされる。   As shown in FIG. 5, the second inclined surfaces 7 on the left and right sides are axisymmetric and have the same shape when viewed from the axial direction, and the first inclined surface 6 and the second inclined surfaces 6 are the same. A ridge line 9 is formed at the boundary of the inclined surface 7. The ridge line 9 is inclined with respect to the radial direction so as to be higher as it goes outward in the radial direction. The length of the second inclined surface 7 in the axial center direction is set as a chamfering length L2, and a chamfering ratio L2 / L1 is set to 0.25 to 0.65, preferably 0.45 ± 0.2. Is done.

注射針を図2に示す状態から周方向の各方向に回動させ、図3及び図4に示すように、側面から見て、左右一方の第2傾斜面7が直線状に見える状態とした際に、第2傾斜面7と軸心Cのなす角度が第2傾斜角(第2ベベル角)βとされる。左右各側の第2傾斜角βは同一とされて、21°〜31°とされ、好ましくは、26±2°とされる。   The injection needle is rotated in each direction in the circumferential direction from the state shown in FIG. 2, and as shown in FIGS. 3 and 4, when viewed from the side, the second inclined surface 7 on one of the left and right sides appears to be linear. At this time, an angle formed between the second inclined surface 7 and the axis C is set to a second inclination angle (second bevel angle) β. The second inclination angles β on the left and right sides are the same and are 21 ° to 31 °, preferably 26 ± 2 °.

図6に示すように、刃面4が上側となる状態で、第2傾斜面7を軸心方向から見た際には、各第2傾斜面7は、径方向外方に向かうに従って、下位となるように、径方向に関しても傾斜している。第2傾斜面7及び上記稜線9の径方向に関する傾斜は、回転砥石の径及び研磨時に回転砥石が左右に回動される角度(回動角度)により定まる。両第2傾斜面7のなす角度である形成角θは、50〜90°とされ、好ましくは、70±10°とされる。この場合、回動角度は、90°〜130°(左右には、45°〜65°)、好ましくは、110±10°(左右には、55±10°)となる。   As shown in FIG. 6, when the second inclined surface 7 is viewed from the axial direction with the blade surface 4 on the upper side, each second inclined surface 7 becomes lower as it goes radially outward. It is also inclined in the radial direction so that The inclination of the second inclined surface 7 and the ridgeline 9 in the radial direction is determined by the diameter of the rotating grindstone and the angle (rotation angle) by which the rotating grindstone is rotated left and right during polishing. The formation angle θ, which is an angle formed by both the second inclined surfaces 7, is 50 to 90 °, and preferably 70 ± 10 °. In this case, the rotation angle is 90 ° to 130 ° (45 ° to 65 ° on the left and right), preferably 110 ± 10 ° (55 ± 10 ° on the left and right).

上記のように構成した実施態様によれば、重症化した内痔核を薬剤(薬液)により治療する際には、シリンジ(図示省略)に本発明の注射針を接続すると共に、シリンジ内に薬剤を吸引した後、注射針を内痔核に穿刺(刺通)する。   According to the embodiment configured as described above, when treating severe internal hemorrhoids with a medicine (medicine solution), the syringe needle of the present invention is connected to a syringe (not shown), and the medicine is placed in the syringe. After aspiration, the needle is punctured (pierced) into the inner hemorrhoid.

この際、注射針の先鋭部2の先端部における、両第2傾斜面7の形成角θが50〜90°とされて、従来の110°よりも小とされ、これにより、先鋭部2の先端部側の横断面積が従来よりも小であると共に、内痔核自体も柔らかいため、内痔核に注射針を小さな刺通抵抗で容易に穿刺(刺通)できる。   At this time, the formation angle θ of the second inclined surfaces 7 at the distal end of the sharpened portion 2 of the injection needle is set to 50 to 90 °, which is smaller than the conventional 110 °. Since the cross-sectional area on the distal end side is smaller than that of the prior art and the inner hemorrhoid itself is soft, the injection needle can be easily punctured (pierced) into the inner hemorrhoid with a small puncture resistance.

尚、刺通抵抗が小であり過ぎると、注射針を内痔核に穿刺したことが明瞭に施術者に伝わり難い場合もあるため、第2傾斜面7の第2傾斜角βが21°〜31°というように、大とされて、これにより、刺通抵抗の増大が図られている。尚、第2傾斜面7の第2傾斜角βを上記よりも小さな値として、刺通抵抗の増大を図らない場合もある。   If the piercing resistance is too small, it may be difficult to clearly tell the practitioner that the injection needle has been pierced into the inner hemorrhoid, so the second inclination angle β of the second inclined surface 7 is 21 ° to 31. As a result, the piercing resistance is increased. In some cases, the second inclination angle β of the second inclined surface 7 is set to a value smaller than the above, and the piercing resistance is not increased.

ところで、注射針を内痔核に穿刺して、注射針の先鋭部2の先端部だけではなく、その基部も内痔核の組織内に挿入していくと、この挿入されていく部分の横断面積が次第に大となるため、注射針の刺通抵抗も次第に大となる。   By the way, when the injection needle is punctured into the inner hemorrhoid and not only the distal end portion of the sharpened portion 2 of the injection needle but also the base portion thereof is inserted into the tissue of the inner hemorrhoid, the cross-sectional area of the inserted portion is increased. Since it gradually increases, the piercing resistance of the injection needle also gradually increases.

この際、注射針を挿入し過ぎると、まず、第1段階として、注射針の先鋭部2の先端部が、内痔核組織下の直腸筋層に挿入され、第2段階として、注射針の先鋭部2の基部が、内痔核組織下の直腸筋層に挿入されることになる。   At this time, if the injection needle is inserted too much, first, as the first step, the tip of the sharpened portion 2 of the injection needle is inserted into the rectal muscle layer under the internal hemorrhoid tissue, and as the second step, the sharpened portion of the injection needle is inserted. The base of part 2 will be inserted into the rectal muscle layer under the internal hemorrhoidal tissue.

上記第1段階では、両第2傾斜面7の形成角θが50〜90°であって、先鋭部2における、直腸筋層に穿刺された先端部の横断面積が従来よりも小であるため、両第2傾斜面7のなす角度に起因する刺通抵抗は小である。しかし、第2傾斜面7の第2傾斜角βが21°〜31°というように大とされて、第2傾斜角βに起因する刺通抵抗が大であると共に、直腸筋層自体が硬いこともあって、注射針の刺通抵抗が増大する。   In the first stage, the formation angle θ of both the second inclined surfaces 7 is 50 to 90 °, and the cross-sectional area of the tip portion pierced into the rectal muscle layer at the sharpened portion 2 is smaller than before. The piercing resistance due to the angle formed by the second inclined surfaces 7 is small. However, the second inclination angle β of the second inclined surface 7 is set to be as large as 21 ° to 31 °, the piercing resistance due to the second inclination angle β is large, and the rectal muscle layer itself is hard. In some cases, the piercing resistance of the injection needle increases.

上記第2段階では、第1傾斜面6の第1傾斜角αは8〜20°と第2傾斜面7の第2傾斜角βよりも小であるため、第2傾斜角に起因する刺通抵抗は小である。しかし、上記第1段階では、両第2傾斜面7の形成角θが50〜90°であると共に、これに起因して、先鋭部2における、直腸筋層に穿刺された先端部の横断面積が従来よりも小である。これに対し、第2段階では、第1傾斜面6が針管1の左右方向(水平方向)の径方向と平行であって、第1傾斜面6が第2傾斜面7、即ち、第1段階よりも上方側及び左右両側(径方向外方側)に大きく出っ張ると共に、これに起因して、先鋭部2における、直腸筋層に穿刺される部分の横断面積が、第1段階よりも急激に増大する。これにより、直腸筋層自体が硬いこともあって、注射針の刺通抵抗が一挙に増大する。   In the second stage, since the first inclination angle α of the first inclined surface 6 is 8 to 20 °, which is smaller than the second inclination angle β of the second inclined surface 7, the piercing caused by the second inclination angle is performed. Resistance is small. However, in the first stage, the formation angle θ of both the second inclined surfaces 7 is 50 to 90 °, and due to this, the cross-sectional area of the tip portion pierced into the rectal muscle layer at the sharpened portion 2 Is smaller than before. On the other hand, in the second stage, the first inclined surface 6 is parallel to the radial direction of the needle tube 1 in the left-right direction (horizontal direction), and the first inclined surface 6 is the second inclined surface 7, that is, the first stage. Bulges to the upper side and the left and right sides (radially outward), and as a result, the cross-sectional area of the portion to be punctured into the rectal muscle layer in the sharpened portion 2 is sharper than in the first stage. Increase. Thereby, the rectal muscle layer itself may be hard, and the piercing resistance of the injection needle increases at a stroke.

尚、注射針の直腸筋層への穿刺を上記のように2段階に分けて説明したが、第2傾斜面7の脇取り長L2が小であるため、実際の注射では、上記第1・第2段階は略同時に起こり、これにより、内痔核組織下の直腸筋層への注射針の穿刺時には、刺通抵抗が飛躍的に増大する。   Although the puncture of the rectal muscle layer of the injection needle has been described in two stages as described above, since the chamfer length L2 of the second inclined surface 7 is small, in actual injection, the first The second stage occurs substantially simultaneously, which dramatically increases the penetration resistance when the injection needle is punctured into the rectal muscle layer under the internal hemorrhoidal tissue.

上記のようにして、注射針を内痔核組織内に確実に穿刺した後、薬剤を内痔核組織内に注入する。   As described above, after the needle is reliably punctured into the internal hemorrhoid tissue, the drug is injected into the internal hemorrhoid tissue.

上記のように、注射針を内痔核組織に穿刺した際に、その刺通抵抗が低く、注射針を内痔核組織下の直腸筋層に誤穿刺した際には、その刺通抵抗が大となるので、薬剤を内痔核組織内に確実に注入でき、内痔核組織下の直腸筋層等の不適切な部位に薬剤を誤って注入することを防止できる。   As mentioned above, when the needle is punctured into the internal hemorrhoid tissue, its puncture resistance is low, and when the needle is accidentally punctured into the rectal muscle layer under the internal hemorrhoid tissue, the puncture resistance is large. Therefore, the drug can be reliably injected into the internal hemorrhoid tissue, and the drug can be prevented from being erroneously injected into an inappropriate site such as the rectal muscle layer under the internal hemorrhoid tissue.

〔試験例1及び比較例1〕
次に、本発明を実施した試験例1と、比較例1により、本発明を更に説明するが、本発明は試験例により限定されるものではない。
[Test Example 1 and Comparative Example 1]
Next, the present invention will be further described with reference to Test Example 1 in which the present invention was implemented and Comparative Example 1. However, the present invention is not limited to the test examples.

外径O.D.を0.51mm、肉厚を0.10mm、刃面長L1を1.7mm、第1傾斜角αを13°、第2傾斜角βを26°、両第2傾斜面の形成角θを70°とした注射針を5本製作し、試験例1とした。又、外径O.D.及び肉厚を上記と同一とし、刃面長L1を2.4mm、第1傾斜角αを10°、第2傾斜角βを18°、両第2傾斜面の形成角θを110°とした注射針を5本製作し、比較例1とした。   O.D. D. Is 0.51 mm, the wall thickness is 0.10 mm, the blade surface length L1 is 1.7 mm, the first inclination angle α is 13 °, the second inclination angle β is 26 °, and the formation angle θ of both second inclination surfaces is 70. Five injection needles with an angle of 0 were produced and designated as Test Example 1. Also, the outer diameter O.D. D. And the wall thickness L1 is the same as described above, the blade face length L1 is 2.4 mm, the first inclination angle α is 10 °, the second inclination angle β is 18 °, and the formation angle θ of both the second inclination surfaces is 110 °. Five injection needles were produced and used as Comparative Example 1.

試験には、図7に示す痔核モデルを使用した。この痔核モデルはシリコーンゴムから成る円盤(円柱)状とされ、内痔核組織を模した上側円盤11と、内痔核組織下の直腸筋層を模した下側円盤12と、これら上側・下側円盤11,12が嵌入されるリング状枠体13を有する。上側円盤11の上面は平坦面とされているが、この上面には、上方に突出する隆起部14が、周方向に間隔を置いて、形成されている。この隆起部14を形成した理由は、注射針の刺通部分の長さを調整するためである。   The hemorrhoid model shown in FIG. 7 was used for the test. This hemorrhoid model is a disc (column) made of silicone rubber, and includes an upper disc 11 that imitates the inner hemorrhoid tissue, a lower disc 12 that imitates the rectal muscle layer under the inner hemorrhoid tissue, and these upper and lower discs. 11 and 12 has a ring-shaped frame 13 into which the 12 and 12 are inserted. The upper surface of the upper disk 11 is a flat surface. On this upper surface, raised portions 14 protruding upward are formed at intervals in the circumferential direction. The reason for forming the raised portion 14 is to adjust the length of the piercing portion of the injection needle.

上記内痔核モデルの上側・下側円盤11,12に上方から、試験例1の各注射針を、20mm/minの刺通速度で、垂直に刺通して、その刺通抵抗を万能試験機(インストロン社製:型番5565)で測定し、その測定結果を平均して、図8の実線で示すように、注射針の痔核モデルに対する挿入量(mm)と刺通抵抗(N)の関係を示すグラフを得た。比較例1の各注射針についても、上記同様に測定し、図8の点線で示すように、注射針の痔核モデルに対する挿入量(mm)と刺通抵抗(N)の関係を示すグラフを得た。   From above the upper and lower disks 11 and 12 of the inner hemorrhoid model, the injection needles of Test Example 1 were pierced vertically at a piercing speed of 20 mm / min, and the piercing resistance was measured using a universal testing machine (instrument Ron, Inc .: Model No. 5565), and the measurement results are averaged, and as shown by the solid line in FIG. 8, the relationship between the insertion amount (mm) and the penetration resistance (N) with respect to the hemorrhoid model of the injection needle is shown. A graph was obtained. Each of the injection needles of Comparative Example 1 was measured in the same manner as described above, and a graph showing the relationship between the insertion amount (mm) of the injection needle with respect to the hemorrhoid model and the penetration resistance (N) was obtained as shown by the dotted line in FIG. It was.

尚、痔核モデルでは、図8の直線Aよりも左側部分、即ち、直線Aよりも注射針の痔核モデルに対する挿入量が小であって、注射針が上側円盤11のみに穿刺されている場合には、注射針が内痔核組織に穿刺されていると見做され、直線Aよりも右側部分、即ち、直線Aよりも注射針の痔核モデルに対する挿入量が大であって、注射針が上側円盤11だけでなく、下側円盤12にも穿刺されている場合には、注射針が直腸筋層に穿刺されていると見做される。   In the hemorrhoid model, when the insertion amount of the injection needle into the hemorrhoid model is smaller than the straight line A in FIG. 8, that is, the straight line A, and the injection needle is punctured only in the upper disk 11. Is considered that the injection needle is pierced into the internal hemorrhoid tissue, the insertion amount of the injection needle into the hemorrhoid model is larger than the straight line A, that is, the injection needle is inserted into the upper disc. When not only 11 but also the lower disc 12 is punctured, it is considered that the injection needle is pierced into the rectal muscle layer.

図8を見れば、注射針が直腸筋層に穿刺された際には、試験例1の刺通抵抗は、比較例1よりも急激に増大する。従って、本発明の注射針を使用すれば、内痔核組織下の直腸筋層等の不適切な部位に薬剤を誤って注入することを防止できる。   Referring to FIG. 8, when the injection needle is punctured into the rectal muscle layer, the puncture resistance in Test Example 1 increases more rapidly than in Comparative Example 1. Therefore, by using the injection needle of the present invention, it is possible to prevent the drug from being erroneously injected into an inappropriate site such as the rectal muscle layer under the internal hemorrhoid tissue.

本発明の一実施態様を示す平面図である。It is a top view which shows one embodiment of this invention. 図1の側面図である。It is a side view of FIG. 図2の注射針を軸心回りに回動させた側面図である。It is the side view which rotated the injection needle of FIG. 2 around the shaft center. 図2の注射針を軸心回りに回動させた側面図である。It is the side view which rotated the injection needle of FIG. 2 around the shaft center. 図1の正面図である。It is a front view of FIG. 図2のA−A線矢視断面図である。FIG. 3 is a cross-sectional view taken along line AA in FIG. 2. 内痔核モデルの縦側断面図である。It is a longitudinal cross-sectional view of an inner hemorrhoid model. 試験結果を示すグラフである。It is a graph which shows a test result.

符号の説明Explanation of symbols

1 針管
2 先鋭部
4 刃面
6,7 第1・第2傾斜面
C 軸心
L1 刃面長
L2 脇取り長
α,β 第1・第2傾斜角
θ 形成角
DESCRIPTION OF SYMBOLS 1 Needle tube 2 Sharp part 4 Blade surface 6,7 1st, 2nd inclined surface C Axis center L1 Blade surface length L2 Side-cutting length α, β 1st, 2nd inclined angle θ Formation angle

Claims (5)

内痔核組織内への薬剤の注射に使用されるものであって、
針管の先端部がその軸心に対して斜めに研磨されて、その研磨面が刃面とされ、
刃面が、基部側にある第1傾斜面と、先端部側の両側にある一対の第2傾斜面を有し、 第2傾斜面と軸心のなす角度である第2傾斜角が、第1傾斜面と軸心のなす角度である第1傾斜角よりも大とされた注射針において、
両第2傾斜面のなす角度である形成角が50°〜90°とされた注射針。
Used to inject drugs into the internal hemorrhoid tissue,
The tip of the needle tube is polished obliquely with respect to its axis, and the polished surface is used as the blade surface.
The blade surface has a first inclined surface on the base side and a pair of second inclined surfaces on both sides on the distal end side, and the second inclined angle, which is an angle formed by the second inclined surface and the axis, In the injection needle that is made larger than the first inclination angle that is an angle formed by one inclined surface and the axis,
An injection needle having a formation angle of 50 ° to 90 °, which is an angle formed by both second inclined surfaces.
第1傾斜角が8〜20°とされた請求項1記載の注射針。   The injection needle according to claim 1, wherein the first inclination angle is 8 to 20 °. 第2傾斜角が21°〜31°とされた請求項1又は2記載の注射針。   The injection needle according to claim 1 or 2, wherein the second inclination angle is 21 ° to 31 °. 刃面の軸心方向の長さである刃面長L1が1.0〜5.0mmとされた請求項1〜3の何れかに記載の注射針。   The injection needle according to any one of claims 1 to 3, wherein a blade surface length L1 which is a length of the blade surface in the axial direction is 1.0 to 5.0 mm. 第2傾斜面の軸心方向の長さを脇取り長L2とした場合に、脇取り比L2/L1が0.25〜0.65とされた請求項4記載の注射針。   The injection needle according to claim 4, wherein when the length of the second inclined surface in the axial direction is set to the side cut length L2, the side cut ratio L2 / L1 is set to 0.25 to 0.65.
JP2005102395A 2005-03-31 2005-03-31 Needle Active JP4826711B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2005102395A JP4826711B2 (en) 2005-03-31 2005-03-31 Needle
PCT/JP2006/306753 WO2006106880A1 (en) 2005-03-31 2006-03-30 Injection needle
KR1020077022383A KR101291970B1 (en) 2005-03-31 2006-03-30 Injection needle
CN2006800099449A CN101151059B (en) 2005-03-31 2006-03-30 Injection needle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005102395A JP4826711B2 (en) 2005-03-31 2005-03-31 Needle

Publications (2)

Publication Number Publication Date
JP2006280503A JP2006280503A (en) 2006-10-19
JP4826711B2 true JP4826711B2 (en) 2011-11-30

Family

ID=37073435

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005102395A Active JP4826711B2 (en) 2005-03-31 2005-03-31 Needle

Country Status (4)

Country Link
JP (1) JP4826711B2 (en)
KR (1) KR101291970B1 (en)
CN (1) CN101151059B (en)
WO (1) WO2006106880A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101321051B1 (en) 2012-05-03 2013-10-23 한국기계연구원 Biopsy needle having multiple micro cutting edge and inner cannular manufacturing method of the same

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5083948B2 (en) * 2007-06-20 2012-11-28 株式会社ユニシス Puncture needle for epidural anesthesia
CN101357246B (en) * 2008-09-24 2011-11-16 杨昌燕 Safe medical needle head and processing method thereof
DE102011112021B4 (en) * 2011-08-31 2013-10-24 Hans Haindl Puncture cannula
JP6073016B2 (en) * 2011-11-04 2017-02-01 ニプロ株式会社 Manufacturing method of injection needle
JP5777074B2 (en) 2013-12-24 2015-09-09 公立大学法人横浜市立大学 Needle
WO2015105162A1 (en) * 2014-01-08 2015-07-16 ニプロ株式会社 Hollow needle and production method for hollow needle
JP6226134B2 (en) * 2014-02-28 2017-11-08 ニプロ株式会社 Puncture needle
EP3248634B1 (en) 2015-01-20 2021-10-27 Terumo Kabushiki Kaisha Injection needle assembly and injector provided therewith for injecting drug solution into upper layer of skin
CN106267450A (en) * 2015-05-19 2017-01-04 广东龙心医疗器械有限公司 Many blade surfaces backcut type needle tubing
ES2704917T3 (en) * 2015-06-02 2019-03-20 Oreal Application pencil with an inclined tip end
WO2016195132A1 (en) * 2015-06-03 2016-12-08 (주)리젠바이오참 Medical injection needle and manufacturing method therefor
EP3437677B1 (en) * 2016-03-28 2021-07-14 Terumo Kabushiki Kaisha Medical puncture needle and method for manufacturing puncture needle
DE102016014445A1 (en) * 2016-07-15 2018-01-18 Acti-Med Ag Needle for piercing a membrane
CN108262672B (en) * 2018-01-11 2019-09-03 温州职业技术学院 A kind of grinding device of syringe needle production equipment
CN109806464B (en) * 2019-03-03 2021-06-04 吉林大学 Needle tip of injection needle and manufacturing method thereof
JP7246278B2 (en) * 2019-07-26 2023-03-27 テルモ株式会社 puncture needle
KR102316030B1 (en) * 2019-10-24 2021-10-25 오대금속 주식회사 Hair transplanter needle made by laser processing
US20210154436A1 (en) * 2019-11-22 2021-05-27 Becton, Dickinson And Company Introducer needle and related devices, systems, and methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5528274Y2 (en) * 1978-05-18 1980-07-05
US5752942A (en) * 1996-06-20 1998-05-19 Becton Dickinson And Company Five beveled point geometry for a hypodermic needle
JP3492543B2 (en) * 1999-03-15 2004-02-03 金子工業有限会社 Injection needle and its manufacturing method
CN1222327C (en) * 2000-07-03 2005-10-12 Dr.日本株式会社 Medical bevel needle
US6749792B2 (en) * 2001-07-09 2004-06-15 Lifescan, Inc. Micro-needles and methods of manufacture and use thereof
JP4025567B2 (en) * 2002-03-29 2007-12-19 テルモ株式会社 Needle

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101321051B1 (en) 2012-05-03 2013-10-23 한국기계연구원 Biopsy needle having multiple micro cutting edge and inner cannular manufacturing method of the same

Also Published As

Publication number Publication date
CN101151059B (en) 2010-05-19
KR20080009065A (en) 2008-01-24
CN101151059A (en) 2008-03-26
JP2006280503A (en) 2006-10-19
WO2006106880A1 (en) 2006-10-12
KR101291970B1 (en) 2013-08-09

Similar Documents

Publication Publication Date Title
JP4826711B2 (en) Needle
JP5704389B2 (en) Medical hollow needle and method for producing medical hollow needle
JP3311920B2 (en) Medical hollow needle
JP3310270B1 (en) Medical injection needle and method of manufacturing the same
JP7260607B2 (en) 5-beveled cannula for blood collection device
CN110573097B (en) Devices and methods for centering and crossing vascular occlusions
EP1359853B1 (en) Ablation atherectomy burr
EP0739639B1 (en) A medical hollow needle and a method of producing thereof
JP2018532513A (en) Needle and related assemblies and methods
CN105455881A (en) Eccentric abrading head for high-speed rotational atherectomy devices
JPH07509634A (en) cannula
JP2022530749A (en) Intravascular device with enhanced 1-beam cleavage pattern
US5199445A (en) Stromal puncture method
WO2016006342A1 (en) Injection needle
JP2008154842A (en) Injection needle
WO2017151807A1 (en) Puncture needle
JP2004016400A (en) Grinding burr
JP2007511300A (en) Needle tip shape that does not depend on the polishing of the injection needle
JP2008029575A (en) Injection needle for spinal anesthesia and its manufacturing method
JP2004248694A (en) Medical needle
CN117260472A (en) Five-bevel needle tube for injection and manufacturing method thereof

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20071205

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101207

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110202

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110817

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110830

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140922

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4826711

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250